Today we cover a large cohort study linking GLP-1 receptor agonists to fewer psychiatric crises in people with schizophrenia and diabetes, a Circulation review on how liver disease affects the heart, and early trial…
All episodes.
47 episodes. A 10‑minute briefing on the newest peer‑reviewed studies, every single day.
Today's episode looks at six new studies: a New England Journal of Medicine review on adult ADHD, a Circulation deep dive into liver disease and cardiovascular risk, a JAMA Pediatrics survey on teen anxiety, a…
Today's briefing covers early SGLT2 inhibitor use in acute heart failure, menin inhibitors transforming treatment for certain genetically defined leukemias, and new seasonal blood pressure guidance from Japan. We…
Today: a large US cohort links adult ADHD to a sharply higher risk of late life cognitive decline, the tinnitus treatment guideline gets a major update, two new looks at atherosclerosis from gut bacteria and immune…
Today we compare SGLT2 inhibitors, semaglutide, and finerenone for diabetic kidney disease, explore how SARS-CoV-2 may trigger diabetes through a protein called IAPP, and look at why sex differences affect response…
Today's briefing covers a landmark New England Journal of Medicine trial of the triple hormone obesity drug retatrutide, real world data on dupilumab for chronic obstructive pulmonary disease, and a Cell study…
A daily briefing on new medical research for clinicians and curious listeners. Today we cover a major obesity drug trial, a surprising look at lean fatty liver disease, treatment data for a rare pediatric nerve…
Today we cover a striking vitamin B2 discovery in cancer immunology from Cell, a Circulation review on anticancer drugs and blood clots, and new guidance on resistant hypertension from the Clinical Journal of the…
A daily briefing on new medical research for clinicians and the curious. Today we cover a phase three trial of the triple hormone agonist retatrutide for obesity, new data on lean fatty liver disease, a sobering look…
Today we cover a major new perioperative cardiology guideline, striking phase three results for the obesity drug retatrutide, a global study on appendicitis treatment delays, and a surprising diet-microbiome link…